Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity

Abstract Hypoimmunogenic human pluripotent stem cells (hPSCs) are expected to serve as an unlimited cell source for generating universally compatible “off-the-shelf” cell grafts. However, whether the engineered hypoimmunogenic hPSCs still preserve their advantages of unlimited self-renewal and multi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yifan Chen, Yanjie Zhou, Zhongshu Zhou, Yujiang Fang, Lin Ma, Xiaoqing Zhang, Jie Xiong, Ling Liu
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2023-01-01
Colección:	Stem Cell Research & Therapy
Materias:	Hypoimmunogenic hPSCs Self-renewal Multilineage differentiation Functional maturity
Acceso en línea:	https://doi.org/10.1186/s13287-022-03233-z
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!